75 related articles for article (PubMed ID: 19943800)
1. The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin.
Libby A; Meier J; Lopez J; Swislocki AL; Siegel D
Metab Syndr Relat Disord; 2010 Feb; 8(1):79-84. PubMed ID: 19943800
[TBL] [Abstract][Full Text] [Related]
2. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes.
Liu BW; Lu Q; Ma CM; Wang SY; Lou DH; Lou XL; Yin FZ
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):600-4. PubMed ID: 19618346
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism.
Tassone F; Procopio M; Gianotti L; Visconti G; Pia A; Terzolo M; Borretta G
Diabet Med; 2009 Oct; 26(10):968-73. PubMed ID: 19900227
[TBL] [Abstract][Full Text] [Related]
6. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of diabetes mellitus in a rural Greek population.
Melidonis AM; Tournis SM; Kompoti MK; Lentzas IL; Roussou VR; Iraklianou SL; Michail IM; Mariolis AM
Rural Remote Health; 2006; 6(1):534. PubMed ID: 16579675
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study.
Li D; Xu T; Takase H; Tokimitsu I; Zhang P; Wang Q; Yu X; Zhang A
Clin Nutr; 2008 Apr; 27(2):203-11. PubMed ID: 18314230
[TBL] [Abstract][Full Text] [Related]
10. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
Panarotto D; Ardilouze JL; Tessier D; Maheux P
Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
[TBL] [Abstract][Full Text] [Related]
11. Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):451-6. PubMed ID: 15049959
[TBL] [Abstract][Full Text] [Related]
12. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
13. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
14. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
16. Association between extended-release niacin treatment and glycemic control in patients with type 2 diabetes mellitus: analysis of an administrative-claims database.
Ambegaonkar BM; Wentworth C; Allen C; Sazonov V
Metabolism; 2011 Jul; 60(7):1038-44. PubMed ID: 21185576
[TBL] [Abstract][Full Text] [Related]
17. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
Sazonov V; Maccubbin D; Sisk CM; Canner PL
Int J Clin Pract; 2013 Apr; 67(4):297-302. PubMed ID: 23521322
[TBL] [Abstract][Full Text] [Related]
18. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients.
Siegel D; Meier J; Maas C; Lopez J; Swislocki AL
Am J Hypertens; 2008 Apr; 21(4):438-42. PubMed ID: 18246056
[TBL] [Abstract][Full Text] [Related]
19. Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
McKenney J; Bays H; Koren M; Ballantyne CM; Paolini JF; Mitchel Y; Betteridge A; Kuznetsova O; Sapre A; Sisk CM; Maccubbin D
J Clin Lipidol; 2010; 4(2):105-112.e1. PubMed ID: 21122637
[TBL] [Abstract][Full Text] [Related]
20. Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.
Goldberg RB; Bittner VA; Dunbar RL; Fleg JL; Grunberger G; Guyton JR; Leiter LA; McBride R; Robinson JG; Simmons DL; Wysham C; Xu P; Boden WE
Am J Med; 2016 Jul; 129(7):753.e13-22. PubMed ID: 27036394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
